Bank of America Securities Sticks to Their Buy Rating for Jazz Pharmaceuticals (JAZZ)
Bank of America Securities analyst Jason Gerberry reiterated a Buy rating on Jazz Pharmaceuticals (JAZZ – Research Report) today and set a ...
Bank of America Securities Keeps Their Hold Rating on Exelixis (EXEL)
Bank of America Securities analyst Jason Gerberry maintained a Hold rating on Exelixis (EXEL – Research Report) today and set a price target of ...
Investor's Business Daily on MSN23h
IBD Rating Upgrades: Teva Pharmaceutical ADR Flashes Improved Relative Price Strength
Teva Pharmaceutical ADR shows improving price performance, earning an upgrade to its IBD Relative Strength Rating ...